SCHEMBL17279451

SCHEMBL17279451

c1ccc(-c2cccc(-c3ccc(-c4ccc(-c5nc(-c6ccc(-c7ccc(-c8cc(-c9ccccc9)cc(-c9ccccc9)c8)cc7)cc6)nc6ccc7ccccc7c56)cc4)cc3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ATM Q13315 2/20 0.48
▸ NPC1 O15118 5/20 0.47
▸ RAB9A P51151 5/20 0.47
▸ MAPT P10636 4/20 0.47
▸ LMNA P02545 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ PTGES O14684 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ WHR1 P49842 1/20 0.42
▸ HTT P42858 4/20 0.41
▸ NPY1R P25929 1/20 0.41
▸ NPY2R P49146 1/20 0.41
▸ MAPK1 P28482 1/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CA P42336 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17279450 1.00 MEN1 (0.48) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279440 1.00 MEN1 (0.48) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279462 1.00 MEN1 (0.48) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279497 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279529 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279457 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279542 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279488 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279535 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A
SCHEMBL17279516 0.99 MEN1 (0.49) MEN1KMT2AATMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150340626-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2015-11-26 — — US disclosed
US-20150340626-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2015-11-26 — — US disclosed
US-20150098900-A1 ANTI-FCRH5 ANTIBODIES GENENTECH, INC 2015-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150098900-A1 ANTI-FCRH5 ANTIBODIES FCGR3B, FCGRT, FCGR1A MEN1 4003/4885KMT2A 2793/4885ATM 4796/4885
US-20150340626-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OR10J3, OCIAD1 MEN1 2273/4885KMT2A 3924/4885ATM 3583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback